MedTrace Logo

microRNA Profile in Early-stage Cervical Cancer

NCT04087785 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2019-09-13

No results posted yet for this study

Summary

Persistent infections with high-risk subtypes of the human papillomavirus (HPV) are recognized as the etiological factor for developing cervical cancer. The aim od this study was to identify a miRNA profile in patients with early-stage cervical cancer with positive lymph node metastasis treated. Formalin-fixed paraffin-embedded (FFPE) tissue samples of patients with a diagnosis of early-stage cervical cancer treated by radical hysterectomy with lymphadenectomy were collected.

Conditions

Sponsors & Collaborators

  • National Institute of Cancerología

    lead OTHER_GOV

Principal Investigators

  • David F Cantú-deLeón, MD, PhD · National Cancer Institute of Mexico

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-01
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04087785 on ClinicalTrials.gov